1. Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design. (28th January 2021) Authors: Domsic, Robyn T; Gao, Shiyao; Laffoon, Maureen; Wisniewski, Steven; Zhang, Yuqing; Steen, Virginia; Lafyatis, Robert; Medsger, Thomas A Journal: Rheumatology Issue: Volume 60:Number 10(2021) Page Start: 4662 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗